General Atlantic, L.P.

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), General Atlantic, L.P. reported 19 stock positions worth $3.2 billion. Its top holding was XP Class A (XP) at 16.4% of the portfolio, followed by Dlocal (DLO, 16.3%) and Alkami Technology (ALKT, 15.4%). Compared with Q1 2024, it sold out of 3 and reduced 2. The biggest sale was an exit from Hireright (HRT).

Most Recent 13F
Q2 2026
Location
New York, NY
CIK
0001017645
Portfolio Value
$3.2B (Q2 2024)
SEC Filing
0000950142-24-002199 ↗ filed Aug 14, 2024

Holdings Value

0$1.0B$2.0B$3.0B$4.0B$5.0B Q1 2024: $4.3B Q1 2024 Q2 2024: $3.2B $3.2B Q2 2024 Q3 2024: $3.5B Q3 2024 Q4 2024: $2.8B Q4 2024 Q1 2025: $3.0B Q1 2025 Q2 2025: $3.6B Q2 2025 Q3 2025: $3.3B Q3 2025 Q4 2025: $2.9B Q4 2025 Q1 2026: $2.1B Q1 2026 Q2 2026: $2.9B Q2 2026

Holdings 19 stocks · $3.2B
XP XP Inc. Class A 16.38% 29,617,733 $521.0M No change
DLO Dlocal Ltd. 16.26% 63,906,695 $517.0M No change
ALKT Alkami Technology Inc. 15.39% 17,186,985 $489.5M Reduce -8.2%
ALHC Alignment Healthcare Inc. 15.00% 60,993,323 $477.0M No change
SQSP Squarespace Inc. Class A 14.56% 10,611,073 $463.0M No change
PHVS Pharvaris NV 4.45% 7,531,252 $141.6M No change
EWCZ European Wax Center Inc. Class A 4.09% 13,110,492 $130.2M No change
AKRO Akero Therapeutics Inc. 3.86% 5,233,989 $122.8M No change
CNTA Centessa Pharmaceuticals Ltd. 2.75% 9,681,818 $87.4M No change
BLND Blend Labs Inc. Class A 1.42% 19,132,440 $45.2M No change
IMCR Immunocore Holdings PLC-ADR 1.34% 1,261,684 $42.8M Reduce -16.3%
RPRX Royalty Pharma PLC Class A 1.24% 1,500,000 $39.6M No change
THRD Third Harmonic Bio Inc. 1.21% 2,958,762 $38.5M No change
RSKD Riskified Ltd. Class A 1.07% 5,324,998 $34.0M No change
SLRN Acelyrin Inc. 0.40% 2,889,668 $12.7M No change
OPEN Opendoor Technologies Inc. 0.37% 6,321,519 $11.6M No change
CONTEXTLOGIC INC - A 0.11% 609,616 $3.5M No change
GROV Grove Collaborative Holdings 0.05% 936,020 $1.7M No change
ADAG Adagene Inc.-ADR 0.03% 264,000 $808K No change

Portfolio Sells Q1 2024 → Q2 2024
HRT Hireright Holdings Corp. Sold out 0.00% −10.64
HCM Hutchmed China-ADR Sold out 0.00% −1.56
IMCR Immunocore Holdings PLC-ADR Reduce -16.3% 1.34% −0.93
MBLY Mobileye Global Inc. Class A Sold out 0.00% −0.89
ALKT Alkami Technology Inc. Reduce -8.2% 15.39% +4.71

Portfolio Buys Q1 2024 → Q2 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 12$2.9BLFTO, DLO, CHYM, ALKT, XP
Q1 2026 12$2.1BDLO, CHYM, XP, ALKT, PHVS
Q4 2025 13$2.9BDLO, CHYM, XP, ALKT, ALHC
Q3 2025 16$3.3BDLO, XP, ALHC, CHYM, ALKT
Q2 2025 15$3.6BDLO, CHYM, ALHC, XP, AKRO
Q1 2025 15$3.0BALHC, DLO, XP, ALKT, AKRO
Q4 2024 16$2.8BDLO, ALHC, ALKT, XP, CNTA
Q3 2024 18$3.5BALHC, XP, DLO, SQSP, ALKT
Q2 2024 19$3.2BXP, DLO, ALKT, ALHC, SQSP
Q1 2024 22$4.3BDLO, XP, ALKT, HRT, SQSP